Results 121 to 130 of about 26,281 (176)

Irreversible electroporation vs. stereotactic body radiotherapy for solitary hepatocellular carcinoma ≤5 cm: A multicenter retrospective study. [PDF]

JHEP Rep
Xu M, Pan J, Yan S, Wang L, Xu D, Zhao Q, Li K, Dong G, Zhang W, Aji T, Jiang T.   +10 more
europepmc   +1 more source

Stereotactic body radiotherapy in patients with bone oligometastases from breast cancer - results from a European multicenter cohort study. [PDF]

Clin Transl Radiat Oncol
Schäfer S, Seiler I, Kästner L, Meents J, Slavik M, Burkon P, Loi M, Bonomo P, von Wachter C, Balermpas P, Schunn AS, Drabke S, Holy R, Klischies K, Wittenstein O, Willner J, Baehr A, Bank P, Partl R, Mader T, Frerker B, Lohaus F, Ehret F, Trommer M, Gkika E, Rühle A, Guckenberger M, Moustakis C, Brunner T, Blanck O, Heggemann JB, Nicolay NH, Nägler F.   +32 more
europepmc   +1 more source

Phase II Study of Dose-Escalated and Convergent Stereotactic Body Radiotherapy for Liver and Pulmonary Oligometastases from Colorectal Cancer. [PDF]

Cancers (Basel)
Nishimura S, Takeda A, Tsurugai Y, Sanuki N, Eriguchi T, Nemoto T.   +5 more
europepmc   +1 more source

Clinical utility of the ESTRO-EORTC classification in oligometastatic disease treated with stereotactic body radiotherapy: a single-institution retrospective study. [PDF]

Clin Exp Metastasis
Goto M, Nonaka T, Maruyama D, Ishii G, Nakamura M, Baba K, Nitta H, Sakurai H.   +7 more
europepmc   +1 more source

Stereotactic body radiotherapy in early-stage hepatocellular carcinoma: a systematic review and meta-analysis. [PDF]

ESMO Gastrointest Oncol
van Vulpen JK, Verwijs MC, Gommers FK, van Eijck van Heslinga RAH, van Meer S, Verstraete CJR, Hagendoorn J, Lam MGEH, Haj Mohammad N, Smits MLJ, Braat MNGJA, Intven MPW, de Bruijne J.   +12 more
europepmc   +1 more source

Lazertinib with stereotactic body radiotherapy in oligometastatic EGFR-mutant non-small-cell lung cancer. [PDF]

ESMO Open
Lee JB, Kim KH, Yoon S, Song SY, Lee SS, Jo S, Ahn HK, Kim HJ, Choi SJ, Park H, Hong MH, Cho BC, Yoon HI, Lim SM.   +13 more
europepmc   +1 more source

The role of stereotactic body radiotherapy in the management of hepatocellular carcinoma with macroscopic vascular invasion: a narrative review. [PDF]

ESMO Gastrointest Oncol
Gerard IJ, Glynn AM, Faye MD, Yan M, Mesci A, Kim TK, Vanner R, Dawson LA.   +7 more
europepmc   +1 more source

Comparative Performance of Stereotactic Body Radiotherapy and Lenvatinib in Unresectable Hepatocellular Carcinoma Complicated by Portal Vein Tumor Thrombosis: A Propensity Score-Matched Cohort Analysis. [PDF]

J Hepatocell Carcinoma
Huang J, Liu FC, Yang Y, Yuan SX, Gu FM, Jiang BG, Pan ZY.   +6 more
europepmc   +1 more source

A Case Report of Preoperative Stereotactic Body Radiotherapy as Part of Multimodal Treatment in Pediatric Extraskeletal Ewing Sarcoma: An Innovative Treatment Strategy. [PDF]

Cureus
Mohammadipour S, Gultekin M, Susam Sen H, Ardicli B, Gedikoglu MG, Orhan D, Oguz B, Bozkurt MF, Varan A, Yildiz F.   +9 more
europepmc   +1 more source

A retrospective comparative evaluation of rectal preparation strategies for patients undergoing stereotactic body radiotherapy for prostate cancer. [PDF]

Br J Radiol
Tran MN, Didiodato G, Lamb A, Quinn P, Kim J, Conway J, Stevens C, Yoon F, McLean J, Gladwish A.   +9 more
europepmc   +1 more source